Haval Shirwan

4.2k total citations
128 papers, 3.3k citations indexed

About

Haval Shirwan is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Haval Shirwan has authored 128 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Immunology, 48 papers in Surgery and 39 papers in Genetics. Recurrent topics in Haval Shirwan's work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (37 papers) and T-cell and B-cell Immunology (34 papers). Haval Shirwan is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (37 papers) and T-cell and B-cell Immunology (34 papers). Haval Shirwan collaborates with scholars based in United States, United Kingdom and Israel. Haval Shirwan's co-authors include Esma S. Yolcu, Nadir Askenasy, Donald V. Cramer, Kutlu G. Elpek, Andrés J. Garcı́a, Isaac Yaniv, Narendra P. Singh, Devon M. Headen, Rajesh Kumar Sharma and Chantale Lacelle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Materials.

In The Last Decade

Haval Shirwan

126 papers receiving 3.3k citations

Peers

Haval Shirwan
Esma S. Yolcu United States
Xunrong Luo United States
D. Keith Bishop United States
Jamil Azzi United States
Henry J. Winn United States
Adriana T. Larregina United States
Eliane Piaggio France
Giorgio Raimondi United States
Hēth Turnquist United States
Mohamed Ezzelarab United States
Esma S. Yolcu United States
Haval Shirwan
Citations per year, relative to Haval Shirwan Haval Shirwan (= 1×) peers Esma S. Yolcu

Countries citing papers authored by Haval Shirwan

Since Specialization
Citations

This map shows the geographic impact of Haval Shirwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haval Shirwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haval Shirwan more than expected).

Fields of papers citing papers by Haval Shirwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haval Shirwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haval Shirwan. The network helps show where Haval Shirwan may publish in the future.

Co-authorship network of co-authors of Haval Shirwan

This figure shows the co-authorship network connecting the top 25 collaborators of Haval Shirwan. A scholar is included among the top collaborators of Haval Shirwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haval Shirwan. Haval Shirwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Jiude, Ryan M. Marquardt, San‐Pin Wu, et al.. (2025). Progesterone signaling in oviductal epithelial cells modulates the immune response to support preimplantation embryonic development. Science Advances. 11(16). eadt6113–eadt6113. 1 indexed citations
2.
Hering, Bernhard J., Michael R. Rickels, Melena D. Bellin, et al.. (2025). Advances in Cell Replacement Therapies for Diabetes. Diabetes. 74(7). 1068–1077. 3 indexed citations
3.
Rachagani, Satyanarayana, et al.. (2024). Establishment of Translational Luciferase-Based Cancer Models to Evaluate Antitumoral Therapies. International Journal of Molecular Sciences. 25(19). 10418–10418. 2 indexed citations
4.
Tarique, Mohammad, et al.. (2024). Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth. Vaccines. 12(3). 340–340. 1 indexed citations
5.
Yolcu, Esma S., et al.. (2024). Bending the Rules: Amplifying PD-L1 Immunoregulatory Function Through Flexible Polyethylene Glycol Synthetic Linkers. Tissue Engineering Part A. 30(7-8). 299–313. 2 indexed citations
6.
Coronel, María M., Stephen W. Linderman, Karen E. Martin, et al.. (2023). Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy. American Journal of Transplantation. 23(11). 1709–1722. 8 indexed citations
7.
8.
Coronel, María M., Karen E. Martin, Michael D. Hunckler, et al.. (2020). Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival. Science Advances. 6(35). eaba5573–eaba5573. 69 indexed citations
9.
Barsoumian, Hampartsoum B., Lalit Batra, Pradeep Shrestha, et al.. (2019). A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells. Cancer Research. 79(4). 783–794. 14 indexed citations
10.
Saucedo‐Cárdenas, Odila, María de Jesús Loera‐Arias, Aracely García‐García, et al.. (2019). A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model. Cancers. 11(1). 96–96. 18 indexed citations
11.
Montes‐de‐Oca‐Luna, Roberto, Odila Saucedo‐Cárdenas, Haval Shirwan, et al.. (2018). Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis. Cancer Investigation. 36(1). 19–27. 1 indexed citations
12.
Yaddanapudi, Kavitha, Kelly M. McMasters, Haval Shirwan, et al.. (2017). Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis. Cancer Biology & Therapy. 19(3). 188–197. 4 indexed citations
13.
Srivastava, Abhishek K., et al.. (2014). SA-4-1BBL and Monophosphoryl Lipid A Constitute an Efficacious Combination Adjuvant for Cancer Vaccines. Cancer Research. 74(22). 6441–6451. 33 indexed citations
14.
Sharma, Rajesh Kumar, Abhishek K. Srivastava, Kutlu G. Elpek, et al.. (2010). 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines. Cancer Research. 70(10). 3945–3954. 44 indexed citations
15.
Sharma, Rajesh Kumar, Kutlu G. Elpek, Esma S. Yolcu, et al.. (2009). Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors. Cancer Research. 69(10). 4319–4326. 63 indexed citations
16.
Yolcu, Esma S., Chantale Lacelle, Hong Zhao, et al.. (2008). Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein. The Journal of Immunology. 181(2). 931–939. 30 indexed citations
17.
Elpek, Kutlu G., et al.. (2007). Ex Vivo Expansion of CD4+CD25+FoxP3+ T Regulatory Cells Based on Synergy between IL-2 and 4-1BB Signaling. The Journal of Immunology. 179(11). 7295–7304. 109 indexed citations
18.
19.
20.
Shirwan, Haval, L Makowka, Elizabeth P. Blankenhorn, & Donald V. Cramer. (1994). Polymerase chain reaction detection of chimerism in rats based on an allelic polymorphism for T cell antigen receptor Cβ genes. Transplant Immunology. 2(3). 253–256. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esma S. Yolcu Breakdown of academic impact, for papers by Xunrong Luo Breakdown of academic impact, for papers by D. Keith Bishop Breakdown of academic impact, for papers by Jamil Azzi Breakdown of academic impact, for papers by Henry J. Winn Breakdown of academic impact, for papers by Adriana T. Larregina Breakdown of academic impact, for papers by Eliane Piaggio Breakdown of academic impact, for papers by Giorgio Raimondi Breakdown of academic impact, for papers by Hēth Turnquist Breakdown of academic impact, for papers by Mohamed Ezzelarab
Rankless by CCL
2026